Skip to main content
    P

    Protara Therapeutics Inc (TARA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $2.38
    -0.15 (-5.93%)

    Market Cap: $155.77M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Protara Therapeutics Inc (TARA) Earnings: Report Dates and Results

    Updated Nov 6, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Protara Therapeutics (TARA) is expected to report earnings on Mar 8, 2027. In the quarter ended Sep 30, 2026, Protara Therapeutics reported EPS of -$0.35, above the -$0.37 estimate. It beat the EPS estimate in 6 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    55%(22/40)
    Avg Surprise
    -22.77%
    Streak
    1 Q

    Upcoming Estimates

    Reports Mar 8, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.37
    Range-$0.37 - -$0.36
    9 analysts
    Revenue Consensus
    N/A
    RangeN/A
    8 analysts
    Reports May 11, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.44
    Range-$0.46 - -$0.42
    2 analysts
    EPS Revisions
    1
    1
    30d
    EPS Estimate DriftChange to current
    90d ago-$0.45+2.2%
    60d ago-$0.43-1.5%
    30d ago-$0.43-1.5%
    7d ago-$0.43-1.5%
    Current-$0.44
    Revenue Consensus
    N/A
    RangeN/A
    3 analysts

    Next Report

    TARA has an expected report date of Mar 8, 2027.

    Earnings History

    Of the 40 quarters below that had an estimate, TARA beat 22, missed 17 and matched 1. The widest gap in the table came in the quarter ended Mar 31, 2020, when EPS landed 341.46% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReported
    Sep 30, 2026-$0.35-$0.37-$0.38 - -$0.34+5.41%BeatN/A60 up, 3 downNov 6, 2026
    Jun 30, 2026-$0.36-$0.33-$0.35 - -$0.25-9.09%MissN/A74 up, 0 downAug 11, 2026
    Mar 31, 2026-$0.31-$0.37-$0.41 - -$0.32+16.22%BeatN/A61 up, 3 downMay 13, 2026
    Dec 31, 2025-$0.38-$0.31-$0.39 - -$0.23-21.79%MissN/A72 up, 1 downMar 10, 2026
    Sep 30, 2025-$0.31-$0.38-$0.41 - -$0.36+18.42%BeatN/A42 up, 1 downNov 10, 2025
    Jun 30, 2025-$0.35-$0.41-$0.52 - -$0.34+14.63%BeatN/A32 up, 0 downAug 11, 2025
    Mar 31, 2025-$0.29-$0.48-$0.53 - -$0.37+39.58%BeatN/A42 up, 0 downMay 8, 2025
    Dec 31, 2024-$0.43-$0.57-$0.59 - -$0.54+23.89%BeatN/A20 up, 2 downMar 5, 2025
    Sep 30, 2024-$0.50-$0.52-$0.56 - -$0.48+3.85%BeatN/A30 up, 0 downNov 12, 2024
    Jun 30, 2024-$0.45-$0.74-$1.09 - -$0.44+39.19%BeatN/A30 up, 0 downAug 6, 2024
    Mar 31, 2024-$0.97-$0.92-$1.07 - -$0.64-5.43%MissN/A41 up, 0 downMay 2, 2024
    Dec 31, 2023-$0.90-$0.92-$1.14 - -$0.60+2.17%BeatN/A40 up, 0 downMar 13, 2024
    Sep 30, 2023-$0.87-$0.98-$1.12 - -$0.66+11.22%BeatN/A40 up, 0 downNov 3, 2023
    Jun 30, 2023-$1.00-$0.94-$1.05 - -$0.67-6.38%MissN/A40 up, 0 downAug 3, 2023
    Mar 31, 2023-$0.80-$0.87-$1.05 - -$0.64+8.05%BeatN/A30 up, 0 downMay 4, 2023
    Dec 31, 2022-$1.55-$0.75-$0.95 - -$0.53-106.67%MissN/A30 up, 0 downMar 8, 2023
    Sep 30, 2022-$0.68-$0.70-$0.86 - -$0.57+2.86%BeatN/A30 up, 0 downNov 3, 2022
    Jun 30, 2022-$0.80-$0.78N/A-2.56%MissN/AN/A0 up, 0 downAug 9, 2022
    Mar 31, 2022-$0.96-$0.77-$1.17 - -$0.54-24.68%MissN/A30 up, 0 downMay 5, 2022
    Dec 31, 2021-$0.91-$0.94-$1.22 - -$0.77+3.19%BeatN/A30 up, 0 downMar 9, 2022
    Sep 30, 2021-$0.96-$0.96-$1.24 - -$0.740.00%In lineN/A40 up, 0 downNov 4, 2021
    Jun 30, 2021-$1.14-$0.96-$1.20 - -$0.73-18.75%MissN/A4N/AAug 5, 2021
    Mar 31, 2021-$1.20-$0.63-$0.92 - -$0.46-90.48%MissN/A3N/AMay 6, 2021
    Dec 31, 2020-$0.44-$0.54-$0.92 - -$0.29+18.52%BeatN/A3N/AMar 11, 2021
    Sep 30, 2020-$1.26-$0.62-$0.75 - -$0.50-103.23%MissN/A2N/ANov 12, 2020
    Jun 30, 2020-$1.22-$0.83N/A-46.99%MissN/A1N/AJul 31, 2020
    Mar 31, 2020-$1.81-$0.41-$0.41 - -$0.41-341.46%MissN/A1N/AMay 13, 2020
    Dec 31, 2019-$2.55-$0.71-$0.71 - -$0.71-259.15%MissN/A1N/AMar 20, 2020
    Sep 30, 2019-$3.20-$3.60N/A+11.11%BeatN/AN/AN/AOct 31, 2019
    Jun 30, 2019-$10.80-$6.80N/A-58.82%MissN/AN/AN/AAug 7, 2019
    Mar 31, 2019-$13.60-$9.00N/A-51.11%MissN/AN/AN/AMay 8, 2019
    Dec 31, 2018-$10.80-$10.20N/A-5.88%MissN/AN/AN/AMar 13, 2019
    Sep 30, 2018-$10.00-$12.00N/A+16.67%BeatN/AN/AN/ANov 7, 2018
    Jun 30, 2018-$11.20-$14.20N/A+21.13%BeatN/AN/AN/AAug 7, 2018
    Mar 31, 2018-$13.60-$13.84N/A+1.73%BeatN/AN/AN/AMay 9, 2018
    Dec 31, 2017-$12.40-$16.80N/A+26.19%BeatN/AN/AN/AMar 14, 2018
    Sep 30, 2017-$28.00-$15.53N/A-80.30%MissN/AN/AN/ANov 7, 2017
    Jun 30, 2017-$13.20-$17.20N/A+23.26%BeatN/AN/AN/AAug 7, 2017
    Mar 31, 2017-$15.60-$16.70N/A+6.59%BeatN/AN/AN/AMay 10, 2017
    Dec 31, 2016-$16.80-$18.30N/A+8.20%BeatN/AN/AN/AMar 16, 2017
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$1.33, after -$2.35 the year before. It was -$69.20 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$1.33N/A
    Dec 31, 2024-$2.35N/A
    Dec 31, 2023-$3.57N/A
    Dec 31, 2022-$3.99N/A
    Dec 31, 2021-$4.21N/A
    Dec 31, 2020-$4.73N/A
    Dec 31, 2019-$30.15N/A
    Dec 31, 2018-$45.60N/A
    Dec 31, 2017-$69.20N/A
    Dec 31, 2016-$69.20N/A

    Frequently Asked Questions About TARA

    When is Protara Therapeutics's next earnings date?

    Protara Therapeutics's next earnings report is expected for Mar 8, 2027.

    Did TARA beat earnings estimates last quarter?

    Yes. Protara Therapeutics reported EPS of -$0.35 for the quarter ended Sep 30, 2026, above the -$0.37 estimate, a 5.41% surprise.

    What EPS do analysts expect from TARA next quarter?

    The consensus EPS estimate for Protara Therapeutics for the quarter ending Dec 31, 2026 is -$0.37 from 9 analysts, with estimates from -$0.37 to -$0.36.

    How often does TARA beat earnings estimates?

    Protara Therapeutics beat the EPS estimate in 6 of the last 8 quarters, with an average surprise of +10.91%.